Bristol Myers Squibb Reverses Its Losing Spree On First-Quarter Beat
Bristol Myers Squibb (BMY) stock reversed higher Thursday after the drugmaker beat Wall Street’s first-quarter expectations and raised…
Bristol Myers Squibb Dives After Schizophrenia Drug Flops In Final-Phase Test
Shares of Bristol Myers Squibb (BMY) tumbled early Wednesday after the company’s schizophrenia drug, Cobenfy, failed in a…